Inhibition of H3N2 Influenza Virus Induced Apoptosis by Selenium Nanoparticles with Chitosan through ROS-Mediated Signaling Pathways-Reference-Cited by-同舟云学术

Inhibition of H3N2 Influenza Virus Induced Apoptosis by Selenium Nanoparticles with Chitosan through ROS-Mediated Signaling Pathways

Published:2023-02-23 Issue:9 Volume:8 Page:8473-8480
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Xu Tiantian¹,Lai Jia¹,Su Jingyao¹,Chen Danyang¹,Zhao Mingqi¹,Li Yinghua¹^ORCID,Zhu Bing¹

Affiliation:

1. Center Laboratory, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, No 318 Renminzhong Road, Yuexiu District, Guangzhou 510120, Guangdong, People’s Republic of China

Funder

Guangzhou Medical University

Natural Science Foundation of Guangdong Province

Scientific and Technological Planning Project of Guangzhou City

Guangdong Provincial Key Laboratory of Functional Supramolecular Coordination Materials and Applications

Guangdong Key Laboratory of Marine Materia

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c07575

Reference38 articles.

1. Influenza in Children

2. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation

3. Influenza

4. Challenges of Making Effective Influenza Vaccines

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanostructures for the Prevention, Diagnosis, and Treatment of COVID‐19: A Review;Particle & Particle Systems Characterization;2024-07-24

2. Medicinal and chemosensing applications of chitosan based material: A review;International Journal of Biological Macromolecules;2024-05

3. Advances and future perspectives of intranasal drug delivery: A scientometric review;Journal of Controlled Release;2024-03

4. Nanoparticle‑based antiviral strategies to combat the influenza virus (Review);Biomedical Reports;2024-02-21

5. Naringenin-induced Oral Cancer Cell Apoptosis Via ROS-mediated Bid and Bcl-xl Signaling Pathway;Current Cancer Drug Targets;2024-01-03